Testing a Nanoparticle Reagent for Imaging Mass Cytometry
Biomacromolecules · 2024
DOI: 10.1021/acs.biomac.4c00801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2024. Verfasst von Mahtab Abtahi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada. Hauptthemen laut MEDLINE: Nanoparticles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada, Standard BioTools Canada Inc..
Abstract (Originalsprache)
Mass cytometry (MC), a powerful single-cell analysis technique, has limitations in detecting low-abundance biomarkers. Nanoparticle (NP) reagents offer the potential for enhancing sensitivity by carrying large numbers of heavy metal isotopes. Here, we report NP reporters for imaging mass cytometry (IMC) based on NaYF4:Yb3+/Er3+ NPs. A two-step ligand exchange was used to coat NP surfaces with either methoxy-PEG2K-neridronate (PEG-Ner) and/or poly(sulfobetaine methacrylate)-neridronate (PSBMA-Ner). Both modifications provided long-term colloidal stability in PBS buffer. IMC measurements on tonsil tissue showed that PSBMA-Ner or a 1:1 mixture of PSBMA-Ner + PEG-Ner effectively suppressed nonspecific binding (NSB) at 2 × 1010 NPs/mL, unlike PEG-Ner alone. However, breast cancer tissue samples showed increased NSB at titers above 2 × 1010 NPs/mL. Reduced NSB with mixed PEG-Ner and PSBMA-Ner coatings opens the door for using heterobifunctional PEGs for the development of NP conjugates with bioaffinity agents, enabling more sensitive and specific MC analyses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada.
- Standard BioTools Canada Inc., Suite 400, 1380 Rodick Road, Markham, ON L3R 4G5, Canada.
- Department of Molecular Genetics, University of Toronto, Toronto, ON M5T 3A1, Canada.
- Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON M5G 1X5, Canada.
- Ontario Institute of Cancer Research, Toronto, ON M5G 1M1, Canada.
- Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.
ORCID-Profile: Yang Liu, Edmond C N Wong, Mitchell A Winnik
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Standard BioTools Canada Inc.
Zitieren
APA
Abtahi, M., Gheiratmand, L., Dinesh, A., Liu, Y., Wong, E. C. N., Cho, H., Majonis, D., Jackson, H. W., Mrkonjic, M., & Winnik, M. A. (2024). Testing a Nanoparticle Reagent for Imaging Mass Cytometry. Biomacromolecules. https://doi.org/10.1021/acs.biomac.4c00801
Vancouver
Abtahi M, Gheiratmand L, Dinesh A, Liu Y, Wong ECN, Cho H, et al. Testing a Nanoparticle Reagent for Imaging Mass Cytometry. Biomacromolecules. 2024. doi:10.1021/acs.biomac.4c00801
BibTeX
@article{Abtahi2024,
author = {Abtahi, Mahtab and Gheiratmand, Ladan and Dinesh, Anuroopa and Liu, Yang and Wong, Edmond C N and Cho, Hyungjun and Majonis, Daniel and Jackson, Hartland W and Mrkonjic, Miralem and Winnik, Mitchell A},
title = {Testing a Nanoparticle Reagent for Imaging Mass Cytometry},
journal = {Biomacromolecules},
year = {2024},
doi = {10.1021/acs.biomac.4c00801}
}
EUVIMED